Ascentage Pharma Group International balance sheet AAPG

Annual Quarterly

Stockholders' equity was $37.6 million. It held $122.4 million in cash and investments against $339.5 million of total debt, net debt of $217.1 million. The current ratio, current assets divided by current liabilities, was 1.26.

USD in millions, except ratios and per-share amounts. The percent under a figure is the change from the year before.

Line
FY 2024
Dec 31, 2024
Assets
Cash
122
Cash and investments
122
Receivables
11
Inventory
1
Total current assets
202
Property and equipment, net
116
Goodwill
3
Liabilities and equity
Accounts payable
13
Total current liabilities
160
Total liabilities
321
Stockholders' equity
38
Debt
Debt due within a year
213
Long-term debt
122
Lease liabilities
4
Total debt
339
Net cash
-217
Ratios
Current ratio
1.26x
Debt to equity
9.04x
Return on equity
-147.97%
How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except ratios and per-share amounts. Cash and investments adds short-term and long-term marketable securities to cash. Debt due within a year is the borrowings that are not already in long-term debt. Total debt is those borrowings plus lease liabilities. Net cash is cash and investments minus total debt. Return on equity and return on assets divide the trailing twelve months of net income by the balance on that date. Debt to EBITDA uses the trailing twelve months of EBITDA. More on our methodology.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
AAPG (Nasdaq)
Fiscal year ends
December 31
Incorporated in
Cayman Islands
Headquarters
Suzhou , Jiangsu
SEC filer status
Non-accelerated filer, Emerging growth company
SEC CIK
2023311

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.